Iron Gate Global Advisors’s ICU Medical ICUI Stock Holding History

Iron Gate Global Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-112	Closed	-$25K	–	144
2018 Q3	$25K	Hold	112	–	–	0.02%	138
2018 Q2	$33K	Buy	+112	New	+$30.6K	0.02%	103

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Iron Gate Global Advisors's ICUI Position: Q4 2018 in Review

Iron Gate Global Advisors sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 112 shares — an estimated $25K sold.

Iron Gate Global Advisors first reported a position in ICUI in Q2 2018 and held it in 2 quarters. The position peaked at $33K in Q2 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

Iron Gate Global Advisors reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
Iron Gate Global Advisors sold 112 ICU Medical shares in Q4 2018, an estimated $25K.
Iron Gate Global Advisors first reported a position in ICU Medical in Q2 2018 and held it in 2 quarters.
Iron Gate Global Advisors's ICU Medical position peaked at $33K in Q2 2018.
294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on Iron Gate Global Advisors's 13F filing for Q4 2018, filed 19 Feb 2019.